BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 80871)

  • 1. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract]   [Full Text] [Related]  

  • 3. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
    Thompson DK; Haddow JE
    Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
    [No Abstract]   [Full Text] [Related]  

  • 4. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N
    Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
    Javadpour N; Soares T
    Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor marker in urology].
    Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
    Javadpour N; Utz M; Soares T
    J Urol; 1980 Nov; 124(5):615-6. PubMed ID: 6161257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
    Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
    Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum alpha fetoprotein and testicular tumors.
    N Engl J Med; 1977 Mar; 296(12):693-4. PubMed ID: 65733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in management of testicular tumor.
    Javadpour N
    Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
    Narayana AS; Loening S; Culp DA
    Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.